Designation was given based on Epidiolex’s potential viability in treating a rare genetic disorder called tuberculosis sclerosis complex, which can induce epilepsy.
Designation was given based on Epidiolex’s potential viability in treating a rare genetic disorder called tuberculosis sclerosis complex, which can induce epilepsy.